Notice: This company has been marked as potentially delisted and may not be actively trading. NYSE:BXLT (BXLT) (BXLT) Stock Price, News & Analysis Add Share Share Stock Analysis Stock Analysis Get (BXLT) alerts: Email Address About (BXLT) Stock (NYSE:BXLT) 30 days 90 days 365 days Advanced Chart Ad Investors AlleyForget Trump and KamalaForget Trump and Kamala. I don't care who you vote for - This calendar is the only thing that matters right now.Download my Dividend Calendar here Get (BXLT) alerts:Sign Up Key Stats Today's Range$46.02▼$46.0250-Day Range N/A52-Week Range$29.83▼$46.52VolumeN/AAverage Volume12.66 million shsMarket CapitalizationN/AP/E Ratio15.49Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewBaxalta Incorporated (Baxalta) is a biopharmaceutical company with a portfolio of differentiated therapies that seek to address medical needs across various disease areas, including hemophilia, immunology and oncology. Baxalta's categories of products include Hemophilia products, such as Advate, Adynovate, Recombinate, Hemofil M, Immunate, Immunine, Rixubis and Prothromplex Total; Inhibitor Therapies products, including FEIBA and OBIZUR; Immunoglobulin Therapies products, which include GAMMAGARD LIQUID/KIOVIG, HYQVIA, GAMMAGARD S/D and SUBCUVIA; BioTherapeutics products, including FLEXBUMIN, BUMINATE, ARALAST NP, GLASSIA NP and CEPROTIN, and Oncology product, such as ONCASPAR. Baxalta Company develops, manufactures and markets a portfolio of treatments for hemophilia and other bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute medical conditions, as well as oncology treatments for acute lymphoblastic leukemia.Read More… Forget Trump and Kamala (Ad)Forget Trump and Kamala. I don't care who you vote for - This calendar is the only thing that matters right now.Download my Dividend Calendar here Receive BXLT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (BXLT) and its competitors with MarketBeat's FREE daily newsletter. Email Address BXLT Stock News HeadlinesAnyMind Group Inc 5027April 5, 2024 | morningstar.comIDICO Corp JSC Ordinary Shares IDCFebruary 25, 2024 | morningstar.com Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!September 20, 2024 | Paradigm Press (Ad)Hana Financial Group Inc 086790February 20, 2024 | morningstar.comBaxter Int'l. (BAX) Stock Price Target Lowered by AnalystsSeptember 15, 2023 | thestreet.comAllergan Could Buy These Drug Companies Now That the Pfizer Merger Is ScuttledAugust 25, 2023 | thestreet.com4 Smart Stocks to Add to Your Portfolio in 2016, from Recon’s Kevin KellyJuly 25, 2023 | thestreet.comFed Beige Book: Pace of hiring and pricing is slowingMay 31, 2023 | msn.comSee More Headlines BXLT Stock Analysis - Frequently Asked Questions How were (BXLT)'s earnings last quarter? (BXLT) (NYSE:BXLT) issued its quarterly earnings data on Thursday, April, 28th. The biotechnology company reported $0.47 earnings per share for the quarter, beating analysts' consensus estimates of $0.46 by $0.01. (BXLT)'s revenue for the quarter was up 10.3% compared to the same quarter last year. What other stocks do shareholders of (BXLT) own? Based on aggregate information from My MarketBeat watchlists, some other companies that (BXLT) investors own include Baxter International (BAX), Hawkins (HWKN), AbbVie (ABBV), Allergan (AGN), Vertex Pharmaceuticals (VRTX), Alibaba Group (BABA) and Bank of America (BAC). Company Calendar Last Earnings4/28/2016Today9/20/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNYSE:BXLT CUSIPN/A CIK1620546 Webwww.baxalta.com Phone+1-224-9402000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio15.49 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report This page (NYSE:BXLT) was last updated on 9/20/2024 by MarketBeat.com Staff From Our PartnersHow the US Will Win the Great Lithium RaceChina spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but i...DealMaker | SponsoredThe Perfect Storm for an EV RevoltWith constant talk about Artifical Intelligence, inflation, and the upcoming election clogging the airwaves......Eagle Publishing | SponsoredTrump’s “Tax Free” Retirement StrategySince 1924 — over one hundred years — the US dollar has lost nearly 18x its value. If you're planning on re...Gold Safe Exchange | SponsoredThe election trade you can't losePolitics is an unpredictable game. But no matter what happens in the next few months... There's one thin...Investors Alley | SponsoredAre You Ready for a Small-Cap Rally?Jeff Bezos has just made a bold move into Quantum Computing as a Service (QaaS), a technology set to disrupt i...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMust-Know for Trading OptionsOptions are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a ...Unstoppable Prosperity | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (BXLT) Please log in to your account or sign up in order to add this asset to your watchlist. Share (BXLT) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.